Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8,387 | 8,045 | 7,372 | 7,480 | 7,367 |
| Income taxes - deferred | 409 | 617 | 254 | 59 | 206 |
| Accounts receivable | 1,006 | 551 | 641 | -1,573 | 1,425 |
| Accounts payable and accrued liabilities | 107 | -1,898 | -1,783 | -146 | 181 |
| Other Working Capital | 1,030 | -434 | -1,714 | -3,016 | 2,143 |
| Other Operating Activity | -5,181 | -2,903 | -1,219 | -1,089 | -4,137 |
| Operating Cash Flow | $5,758 | $3,978 | $3,551 | $1,715 | $7,185 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -22 | -10 | -9 | -6 |
| Purchase Sale Intangibles | -26 | -400 | -192 | -2,523 | -1,348 |
| Investing Cash Flow | $-35 | $-422 | $-202 | $-2,532 | $-1,354 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,159 | -3,161 | -3,159 | -2,412 | -2,405 |
| Common Stock Repurchased | -21 | 0 | N/A | N/A | N/A |
| Dividend Paid | -1,282 | -1,269 | -1,276 | -1,310 | -1,267 |
| Other Financing Activity | 165 | 260 | 1,550 | 2,639 | 412 |
| Financing Cash Flow | $-4,297 | $-4,170 | $-2,885 | $-1,083 | $-3,260 |
| Exchange Rate Effect | 59 | 57 | -75 | 44 | 20 |
| Beginning Cash Position | 21,179 | 21,736 | 21,347 | 23,203 | 20,612 |
| End Cash Position | 22,664 | 21,179 | 21,736 | 21,347 | 23,203 |
| Net Cash Flow | $1,426 | $-614 | $464 | $-1,900 | $2,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,758 | 3,978 | 3,551 | 1,715 | 7,185 |
| Capital Expenditure | -35 | -422 | -202 | -2,532 | -1,354 |
| Free Cash Flow | 5,723 | 3,556 | 3,349 | -817 | 5,831 |